Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Efficacy of IPL, an Anti-redness Dermocosmetic, and Their Combination in the Treatment of Rosacea

NCT: NCT07729540 · COMPLETED

NCT IDNCT07729540
StatusCOMPLETED
Start Date2025-09-29
Completion2026-04-30
SponsorMedical University of Silesia (OTHER)
First posted
Last updated

Brief Summary

This study compares three approaches to treating persistent facial redness in adults with erythematotelangiectatic rosacea: intense pulsed light (IPL) treatment alone, a professional anti-redness dermocosmetic skincare regimen alone, and the combination of both. The main question the study aims to answer is which of these three strategies is more effective at reducing facial redness, using both clinician grading and objective skin-imaging tools that measure redness and skin texture before and after treatment.

Frequently Asked Questions

What is Efficacy of IPL, an Anti-redness Dermocosmetic, and Their Combination in the Treatment of Rosacea?

Efficacy of IPL, an Anti-redness Dermocosmetic, and Their Combination in the Treatment of Rosacea is a clinical trial registered under NCT07729540. Current status: COMPLETED.

What is the status of NCT07729540?

The current status of NCT07729540 (Efficacy of IPL, an Anti-redness Dermocosmetic, and Their Combination in the Treatment of Rosacea) is: COMPLETED.

When did Efficacy of IPL, an Anti-redness Dermocosmetic, and Their Combination in the Treatment of Rosacea start?

Efficacy of IPL, an Anti-redness Dermocosmetic, and Their Combination in the Treatment of Rosacea started on 2025-09-29.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.